Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Greensboro, NC
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Greensboro, NC
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
High Point, NC
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
High Point, NC
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dayton, OH
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Norman, OK
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Portland, OR
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Anderson, SC
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anderson, SC
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chattanooga, TN
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chattanooga, TN
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kingsport, TN
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Austin, TX
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Virginia Beach, VA
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bellevue, WA
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jackson, MI
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jackson, MI
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Investigational Site
mi
from
Tbilisi,
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Investigational Site
mi
from
Tbilisi,
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Montclair, CA
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Montclair, CA
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Redlands, CA
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Redlands, CA
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Colorado Springs, CO
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Research Site
mi
from
Lisle, IL
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Research Site
mi
from
Lisle, IL
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Staten Island, NY
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Edmond, OK
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Edmond, OK
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Smithfield, PA
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Smithfield, PA
Click here to add this to my saved trials
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Myers, FL
A Multicenter Assessment of ALD403 in Frequent Episodic Migraine
A Parallel Group, Double-Blind, Randomized, Placebo Controlled, Trial to Evaluate the Efficacy and Safety of ALD403 Administered Intravenously in Patients With Frequent Episodic Migraines
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Orange Grove Family Practice
mi
from
Tucson, AZ
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Orange Grove Family Practice
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research
mi
from
Carmichael, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research
mi
from
Carmichael, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Newport Beach
mi
from
Encino, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Newport Beach
mi
from
Encino, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Tooraj Joseph Raoof M.D., Inc.
mi
from
Encino, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Tooraj Joseph Raoof M.D., Inc.
mi
from
Encino, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Fullerton Neurology and Headache Center
mi
from
Fullerton, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Fullerton Neurology and Headache Center
mi
from
Fullerton, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Sun Valley Research Center
mi
from
Imperial, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Sun Valley Research Center
mi
from
Imperial, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Irvine Clinical Research Center
mi
from
Irvine, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Irvine Clinical Research Center
mi
from
Irvine, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Newport Beach
mi
from
Los Alamitos, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Newport Beach
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute, Newport Beach
mi
from
Newport Beach, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute, Newport Beach
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Desert Valley Research
mi
from
Rancho Mirage, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Desert Valley Research
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Anderson Clinical Research
mi
from
Redlands, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Anderson Clinical Research
mi
from
Redlands, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Medical Center for clinical research
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Alpine Clinical Research Center
mi
from
Boulder, CO
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Alpine Clinical Research Center
mi
from
Boulder, CO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Mile High Research Center
mi
from
Denver, CO
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Mile High Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Colorado Neurological Institute
mi
from
Englewood, CO
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Colorado Neurological Institute
mi
from
Englewood, CO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Advanced Neurosciences Research, LLC
mi
from
Fort Collins, CO
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Advanced Neurosciences Research, LLC
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated:  12/31/1969
Chase Medical Research, LLC
mi
from
Waterbury, CT
Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 Study
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-1 Study
Status: Enrolling
Updated: 12/31/1969
Chase Medical Research, LLC
mi
from
Waterbury, CT
Click here to add this to my saved trials